Unleashing the Power of Neoantigens
Watch this on-demand keynote featuring Julie Gil, Senior Scientific Partner at Velsera, as she explores how neoantigen discovery is transforming cancer care.
Julie dives into the intersection of bioinformatics, immunology, and machine learning, showcasing how neoantigens are driving the next wave of personalized cancer therapies and innovative immunotherapies.
Whether you’re a researcher, clinician, or innovator, this talk offers valuable insights into the technologies and strategies pushing the boundaries of precision medicine.
Watch now to discover how neoantigens could revolutionize treatment and improve patient outcomes.